Kula Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
$510K Buy
5,041
+1,861
+59% +$188K 0.13% 295
2022
Q4
$380K Buy
+3,180
New +$380K 0.11% 297